Director, Evidence Program Management II - Mississauga, Canada - Workday

Description

At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe.

Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office and BlueSky Hub in downtown Toronto are purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.

Our dedication to sustainability is also central to our culture and part of what makes AstraZeneca a great place to work. We know the health of people, the planet and our business are interconnected which is why we're taking ambitious action to tackle some of the biggest challenges of our time, from climate change to access to healthcare and disease prevention.

Director, Evidence Program Management II (Dir EPM II) is accountable for portfolio level oversight within assigned tumor area. This role also assumes strategic activities in support of Sr. Director, Evidence Program Management and serves as Sr. Director, Evidence Program Management deputy as needed.

Director, Evidence Program Management II (Dir EPM II) is accountable for the overall portfolio management of all company sponsored global studies within the assigned therapeutic area (TA) and/or early access programs (EAP) overseen by Director, Evidence Program Management I (Dir EPM I) and delivered by Associate Directors, Evidence Program Management (AD EPM), covering all program and study deliverables. Overseeing quality, budget, time, resource and risk, the Dir EPM II will have the ability to ensure and optimize the delivery of a suite of evidence studies and/or early access programs, developing operational strategies to optimise trial execution. The role also involves integrating design, feasibility, and operational planning in close collaboration with the Senior Director, Evidence Program Management (Sr Dir EPM) to achieve operational excellence in an aligned organization.

The Dir EPM II is accountable for line management and providing expert input, guidance, direction, mentoring, and support to direct reports on all study related operational activities as well as accountability for coaching and mentoring of soft skill capability development. The Dir EPM II will also provide advice and support on study related operational activities as needed, as well as coaching and mentoring support of soft skill and leadership capability development across Evidence Delivery team as needed.

Responsibilities:

• Partner with Sr Dir EPM ensuring provision of expertise and operational input into the programs and/or studies (e.g. IMAP, ERT, MARCO, SDC, CSP, High impact proposals (HIPs))
• Responsible to serve as AZ single point of contact for alliance studies (eg Daiichi, Merck) with responsibility for activities such as protocol reviews, governance meeting participation and alliance resource need assessments
• Lead CRO selection in partnership with Sr Dir EPM, Director, Evidence Program Management I (Dir EPM I), and/or AD EPM
• Responsible for partnering with relevant R&D stakeholders within assigned tumor area to align on site selection strategy during early planning phase throughout site selection activities

Project management area of expertise:

• Portfolio-level interface with externally managed/outsourced partners for studies planning and delivery
• Responsible for integrating design, feasibility and operational planning to ensure that all AZ sponsored studies within assigned tumor area are aligned with priorities and strategy
• Accountable for oversight of all project management of deliverables in planning phase within assigned tumor area
• Interface with key stakeholders cross-functionally, and/or external partners, to identify, manage and resolve issues affecting program delivery
• Oversee portfolio level performance across all AZ sponsored studies against agreed upon plans, milestones and key performance metrics
• Main escalation point for Director, Evidence Program Management I (Dir EPM I), and/or AD EPM to manage performance of CRO and execute contractual obligations

Line management/Team capability build area of expertise:

• Develop, maintain and conduct individually tailored induction training for newcomers in the assigned tumor area
• Set the clear individual and collective goals for direct reports, along with IDPs and monitor the progress over time
• Support staff/team to achieve study milestones and all respective deliverables
• Support recruitment and retention processes within Evidence Delivery Team

Requirements:

Essential:

• Bachelor's degree required preferably in medical or biological science or equivalent by experience
• Extensive pharmaceutical industry/CRO experience within clinical study/research project delivery, drug development process and relevant guidelines, for example GCP/ICH, for a specific therapeutic and geographical area
• Project Management qualification or demonstration of project management skills including scope, budget, timeline, resource management and use of associated tools
• Ability to effectively work with Clinical Research Organisations/External Providers
• Ability to mentor, develop and educate staff
• Proven leadership promoting motivation and empowerment of others in order to accomplish individual, team and organisational objectives
• Ability to look for and champion more efficient and effective methods/processes of delivering evidence studies focusing on key performance metrics around reliability, efficiency, cost and quality
• Strong problem solving, stakeholder management and conflict resolution skills
• Ability to lead change with a positive approach to the challenges of change for self, team and the business
• See change as an opportunity to improve performance and add value to the business
• Proven ability to interact widely and effectively within the company across regions, functions and cultures
• Persuasive communicator in English with a proven ability to work collaboratively in a multi-cultural environment
• Demonstrated ability to set and lead priorities, resources, performance targets and project initiatives in a regional and local environment

Desirable:

• Experience and knowledge within compliant management of Early Access Program
• Advanced degree in medical or biological sciences or field associated with clinical research
• Experience of incorporating digital health and patent centric strategies into clinical studies

#LI-Hybrid

Great People want to Work with us Find out why:

• GTAA Top Employer Award for 10 years
• Top 100 Employers Award
• Canada's Most Admired Corporate Culture
• Learn more about working with us in Canada
• View our YouTube channel

Are you interested in working at AZ, apply today

AstraZeneca is an equal opportunity employer that is committed to diversity and inclusion and providing a workplace that is free from discrimination. AstraZeneca is committed to accommodating persons with disabilities. Such accommodation is available on request in respect of all aspects of the recruitment, assessment and selection process and may be requested by emailing

Date Posted

Closing Date

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.